4-(3-(Benzylamino)butyl)-2-methoxyphenol

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 4-(3-(Benzylamino)butyl)-2-methoxyphenol
• 英文别名: 4-[3-(benzylamino)butyl]-2-methoxyphenol
• 化学式: C₁₈H₂₃NO₂
• 分子量: 285.386
• InChiKey: GEKRZHUGDNWIIB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  21
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  41.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-((2-溴-1-氧代)乙基)-2-甲基苯磺酰胺 、 4-(3-(Benzylamino)butyl)-2-methoxyphenol 生成 5-{1-Hydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-1-methyl-propylamino]-ethyl}-2-methyl-benzenesulfonamide
  参考文献：
  名称：

  DE2843016

  摘要：

  公开号：

文献信息

• COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
  申请人：COGNITION THERAPEUTICS, INC.

  公开号：US20170197977A9

  公开（公告）日：2017-07-13

  This invention relates to novel diarylamino compounds that bind to the sigma-2 receptor, to pharmaceutical compositions comprising such compounds, and to methods for inhibiting or restoring synapse loss in neuronal cells, modulating a membrane trafficking change in neuronal cells, and treating cognitive decline and neurodegenerative diseases and disorders therewith.

  这项发明涉及与sigma-2受体结合的新型二芳胺化合物，包括这种化合物的药物组合物，以及用于抑制或恢复神经元细胞中突触丢失，调节神经元细胞中膜运输变化，并用于治疗认知衰退和神经退行性疾病和障碍的方法。
• [EN] COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE<br/>[FR] COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
  申请人：COGNITION THERAPEUTICS INC

  公开号：WO2013029057A2

  公开（公告）日：2013-02-28

  This invention relates to novel diarylamino compounds that bind to the sigma-2 receptor, to pharmaceutical compositions comprising such compounds, and to methods for inhibiting or restoring synapse loss in neuronal cells, modulating a membrane trafficking change in neuronal cells, and treating cognitive decline and neurodegenerative diseases and disorders therewith.
• [EN] COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
  申请人：COGNITION THERAPEUTICS INC

  公开号：WO2013029060A2

  公开（公告）日：2013-02-28

  This invention relates to the use sigma-2 receptor antagonists, and of pharmaceutical compositions comprising such compounds, in methods for inhibiting Abeta- associated synapse loss or synaptic dysfunction in neuronal cells, modulating an Abeta-associated membrane trafficking change in neuronal cells, and treating cognitive decline associated with Abeta pathology and more broadly treating with such compounds and compositions neurodegenerative diseases and disorders associated with Abeta pathology. This invention also relates to methods for screening compounds for activity in inhibiting cognitive decline on the basis of their ability to bind to a sigma-2 receptor.
• DE2843016
  申请人：——

  公开号：——

  公开（公告）日：——